A University of New Mexico study has found that cannabis may be an effective treatment option for schizophrenia, according to a report on the research. The report was published last week in the journal Medicines by Jegason P. Diviant and Jacob M. Vigil of the University of New Mexico Department of Psychology and Sarah S. Stith of the university’s Department of Economics.
‘Safe and Effective Treatment Option’
The researchers reviewed previous data on the impact of environmental factors, particularly the effect of auto-immune activity, in the expression of schizophrenic profiles. The authors also explored the role of cannabis therapy in regulating immunological function.
The results of the study found that cannabis can be an effective treatment for schizophrenia, either alone or in conjunction with other medications.
“A review of the literature shows that phytocannabinoid consumption may be a safe and effective treatment option for schizophrenia as a primary or adjunctive therapy,” the study’s authors wrote.